App-Quantinova.ai

COVID-19 and Steroids- How well are we monitoring blood glucose levels?

Aye Me-Me-Ko - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Dexamethasone

Design of a phase 2, double-Blind, placebo-controlled trial of setmelanotide in patients with genetic variants in the melanocortin-4 receptor pathway

Sadaf Farooqi - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

setmelanotide

The relation between insulin resistance and both growth hormone and insulin-like growth factor (IGF-1) levels in a sample of Iraqi patients with type 2 diabetes

Hasanain Mohammed Alrubyae - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Type 1 diabetes mellitus

hGH

Management of patients with Diabetes Mellitus and concurrent Covid-19 infection at a centre in Manchester with tertiary diabetes services: A retrospective single-centre audit

Amr Mohammed - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Diabetes

N/A

Immunotherapy-induced Diabetes Mellitus is not uncommon

Janessa Bell - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Addison's disease

Pembrolizumab

Sound mind at the expense of diabetes: olanzapine induced hyperosmolar hyperglycaemic state (HHS) in acute setting

Patricia Kessy - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Abdominal aortic aneurysm

Atorvastatin

Diabetes and cervical pathologies: The phenotype and genotype connection

Prakhar Gupta - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Diabetes

N/A

Changing trends in the aetiology of diabetes-related ketoacidosis(DKA)- a blueprint to identify preventable causes

Dineshwaran Rajendran - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Type 1 diabetes mellitus

N/A

DKA registry: A step towards harmonising management of diabetes-related ketoacidosis in the United Kingdom-initial findings

Catherine Cooper - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Health outcomes following engagement with a digital health tool GroHealth app amongst people with type 2 diabetes

Farah Abdelhameed - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

N/A

Case Report: A triad of Diabetic Ketoacidosis, hypertriglyceridaemia and acute pancreatitis as a first presentation of diabetes mellitus

Ebo Dadey - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

N/A

Understanding and improving the management of hyperosmolar hyperglycaemic state

Carina Synn Cuen Pan - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Uncommon side effect of a common drug: doxycycline induced hypoglycaemia

Elohor Ijete - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

Doxycycline

Glucokinase (GCK) diabetes

Mona Abouzaid - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 1 diabetes mellitus

N/A

Differential localisation of the A-ring reductases in human hepatocytes: implications for substrate preference and utilisation

Tom Potter - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

Dihydrotestosterone

When and How to Screen for Glucose Dysregulation (GD) in patients with β-Thalassemia Major (β-TM): A retrospective study by The International Network of Clinicians for Endocrinopathies in Thalassemia and Adolescent Medicine (ICET-A)

Vincenzo De Sanctis - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Beta-thalassemia

Methadone hydrochloride

Ketosis prone type 2 diabetes in covid times - a missing link?

Bhavna Sharma - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Type 1 diabetes mellitus

N/A

Covid-19, Dexamethasone and Diabetes(CODED) study: a single centre experience

Noha Meneissy - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Diabetes

Dexamethasone

Comparing global rating scores from simulation-based diabetes and endocrine scenarios between healthcare professionals of high- and low- and middle-income countries

Zakee Abdi - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Waist-to-height ratio is a predictor of weight loss with Gelesis200 treatment for people with overweight or obesity having prediabetes or type 2 diabetes in the LIGHT-UP study

Livio Luzi - European Congress of Endocrinology (ECE) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Type 2 diabetes mellitus

N/A

Filters

45280 Abstracts